A 6.3% revenue growth and 17.7% PAT decline YoY with EBITDA margin drop of 370bps is expected
We expect healthcare companies to report recovery in revenue growth for the quarter ended Sep'17. This would be mainly on account of recovery in domestic formulations from negative growth in Q1FY18 which got impacted by GST implementation. However, we expect EBITDA margin decline of 370bps YoY due to continued pressure on US business and increased R&D spend. The margin and PAT decline would be primarily due to substantial drop in Sun Pharma earnings.
Increased competition and pricing pressure would continue to impact growth in US -focussed companies. We expect weak results from:
1) Sun Pharma due to continued pricing pressure in Taro portfolio and FDA issues at Halol plant,.
2) Apollo Hospitals on lower occupancy and losses in Navi Mumbai Hospital. Overall, we expect the companies to report 6.3% revenue growth and 17.7% PAT decline YoY with EBITDA margin drop of 370bps.
Some key pointers
Denne historien er fra November 2017-utgaven av Healthcare Radius.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra November 2017-utgaven av Healthcare Radius.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Centre For Sight forms JV with Laxmi Eye Hospital
Expands in Maharashtra; to collaborate with Laxmi Eye Hospital for local market reach.
Diverse information sources are reshaping treatment patterns - Study
A CLIRNET study finds that doctors exposed to multichannel content, demonstrate a 50 percent higher likelihood of diversifying their treatment patterns.
Advanced test for IRD diagnosis launched
Nucleome Informatics unveils an advanced genetic test for diagnosing inherited retinal diseases (IRDS
A device for facial muscle toning, anti-aging. Interested?
Dr Rickson's Dermatherapie Clinic launches device for facial muscle toning, lifting, tightening, and texture improvement.
Therapeutics startup Wundrsight raises $400K in seed round
Wundrsight secures $400,000 in seed round led by Inflection Point Ventures. The fresh funds will be utilized in development of company's VR-based mental health solutions
Odisha's Komal Panda wins James Dyson award
Komal Panda wins the James Dyson Award 2024 for her innovation for diabetes patients, Novocarry, a portable cooling carrier that helps in keeping insulin under desired temperatures.
REHABILITATION SERVICES: AN EVOLVING LANDSCAPE
India's healthcare rehabilitation services market is rapidly evolving, driven by rising demand and investments.
FIVE CYBERKNIFE RADIOSURGERY BENEFITS IN HEAD AND NECK CANCER TREATMENT
Explore why cyberknife radiosurgery promises to be a game-changer in head and neck cancer treatment by revolutionizing care and improving patient outcomes.
CARING FOR THE ELDERLY
India's aging population presents a pressing need for comprehensive healthcare services. Learn how the country's healthcare system can address this challenge.
TACKLING INDIA'S IMMUNIZATION CHALLENGE
India's vast geography and large population challenge comprehensive immunization. Despite successes in children's immunization, more work is needed. A report.
